Neptune Technologies & Bioressources Inc (CVE:NTB) is scheduled to be posting its quarterly earnings results after the market closes on Monday, August 14th.

TRADEMARK VIOLATION WARNING: “Neptune Technologies & Bioressources Inc (NTB) to Release Quarterly Earnings on Monday” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/08/07/neptune-technologies-bioressources-inc-ntb-to-release-quarterly-earnings-on-monday.html.

Neptune Technologies & Bioressources Company Profile

Neptune Technologies & Bioressources Inc (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc and Acasti Pharma Inc Its Neptune produces and commercializes nutraceutical products.

Receive News & Ratings for Neptune Technologies & Bioressources Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioressources Inc and related companies with MarketBeat.com's FREE daily email newsletter.